Usefulness of erythrocyte-bound C4d as a biomarker to predict disease activity in patients with systemic lupus erythematosus

Rheumatology

Volumn 48, Issue 9, 2009, Pages 1083-1087

  Yang, Deng Ho ^a,b   Chang, Deh Ming ^b   Lai, Jenn Haung ^b   Lin, Fu Huang ^c   Chen, Chen Hung ^b  

^a TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Autoimmune haemolytic anaemia; Complement; E C4d; Systemic lupus erythematosus

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT COMPONENT C4D; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; PEPTIDE FRAGMENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; HEMOLYTIC ANEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; AGED; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD; CROSS-SECTIONAL STUDY; EVALUATION; HOSPITALIZATION; IMMUNOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANEMIA, HEMOLYTIC, AUTOIMMUNE; BIOLOGICAL MARKERS; COMPLEMENT C4B; CROSS-SECTIONAL STUDIES; ERYTHROCYTES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 70349785353     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep161     Document Type: Article

References (28)

1. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
2. Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 2004;22:431-56.
3. Manzi S, Ahearn JM, Salmon J. New insights into complement: a mediator of injury and marker of disease activity in systemic lupus erythematosus. Lupus 2004;13:298-303.
4. Sturfelt G, Truedsson L. Complement and its breakdown products in SLE. Rheumatology 2005;44:1227-32.
5. Liu CC, Manzi S, Ahearn JM. Biomarkers for systemic lupus erythematosus: a review and perspective. Curr Opin Rheumatol 2005;17:543-9.
6. Merrill JT, Buyon JP. The role of biomarkers in the assessment of lupus. Best Pract Res Clin Rheumatol 2005;19:709-26.
7. Manzi S, Navratil JS, Ruffing MJ et al. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. Arthritis Rheum 2004;50:3596-604.
8. Singh V, Mahoney JA, Petri M. Erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. J Rheumatol 2008;35:1989-93.
9. Giles CM, Robson T. Immunoblotting human C4 bound to human erythrocytes in vivo and in vitro. Clin Exp Immunol 1991;84:263-9.
10. Navratil JS, Manzi S, Kao AH et al. Platelet C4d is highly specific for systemic lupus erythematosus. Arthritis Rheum 2006;54:670-4.
11. Mehta N, Uchino K, Fakhran S et al. Platelet C4d is associated with acute ischemic stroke and stroke severity. Stroke 2008;39:3236-41.
12. Liu CC, Manzi S, Kao AH, Navratil JS, Ruffing MJ, Ahearn JM. Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus. Arthritis Rheum 2005;52:3087-99.
13. Freysdottir J, Sigfusson A. A flow cytometric assay for measuring complement receptor 1 (CR1) and the complement fragments C3d and C4d on erythrocytes. J Immunol Methods 1991;142:45-52.
14. McClain MT, Arbuckle MR, Heinlen LD et al. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum 2004;50:1226-32.
15. Ramos-Casals M, Campoamor MT, Chamorro A et al. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients. Lupus 2004;13:777-83.
16. Rosse WF, Hillmen P, Schreiber AD. Immune-mediated hemolytic anemia. Hematology Am Soc Hematol Educ Program 2004;48-62.
17. Brodsky RA. Narrative review: paroxysmal nocturnal hemoglobinuria: the physiology of complement-related hemolytic anemia. Ann Intern Med 2008; 148:587-95.
18. Packman CH. Hemolytic anemia due to warm autoantibodies. Blood Rev 2008;22:17-31.
19. Petz LD. Cold antibody autoimmune hemolytic anemias. Blood Rev 2008;22:1-15.
20. Ruiz-Arguelles A, Llorente L. The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias. Autoimmun Rev 2007;6:155-61.
21. Walport MJ. Complement and systemic lupus erythematosus. Arthritis Res 2002;4(Suppl. 3):S279-93.
22. Wu YL, Hauptmann G, Viguier M, Yu CY. Molecular basis of complete complement C4 deficiency in two North-African families with systemic lupus erythematosus. Genes Immun. Advance Access published March 12, 2009, doi:10.1038/gene.2009.10.
23. Yang Y, Chung EK, Zhou B et al. The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun 2004;7:98-132.
24. Yang Y, Lhotta K, Chung EK, Eder P, Neumair F, Yu CY. Complete complement components C4A and C4B deficiencies in human kidney diseases and systemic lupus erythematosus. J Immunol 2004;173:2803-14.
25. Ittiprasert W, Kantachuvesiri S, Pavasuthipaisit K et al. Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations. J Autoimmun 2005;25:77-84.
26. Kallel-Sellami M, Baili-Klila L, Zerzeri Y et al. Hereditary complement deficiency and lupus: report of four Tunisian cases. Ann N Y Acad Sci 2007;1108:197-202.
27. Bussone G, Mouthon L. Autoimmune manifestations in primary immune deficiencies. Autoimmun Rev 2009;8:332-6.
28. Janko C, Schorn C, Grossmayer GE et al. Inflammatory clearance of apoptotic remnants in systemic lupus erythematosus (SLE). Autoimmun Rev 2008;8:9-12.